- Home
- TCRX vs LFVN Comparison
TCRX vs LFVN Comparison
Compare TCRX & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- LFVN
- Stock Information
- Founded
- TCRX 2018
- LFVN N/A
- Country
- TCRX United States
- LFVN United States
- Employees
- TCRX N/A
- LFVN N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- TCRX Health Care
- LFVN Health Care
- Exchange
- TCRX Nasdaq
- LFVN Nasdaq
- Market Cap
- TCRX 140.7M
- LFVN 145.2M
- IPO Year
- TCRX 2021
- LFVN N/A
- Fundamental
- Price
- TCRX $1.92
- LFVN $8.15
- Analyst Decision
- TCRX Strong Buy
- LFVN Strong Buy
- Analyst Count
- TCRX 5
- LFVN 2
- Target Price
- TCRX $9.40
- LFVN $30.50
- AVG Volume (30 Days)
- TCRX 648.1K
- LFVN 121.3K
- Earning Date
- TCRX 11-07-2025
- LFVN 11-04-2025
- Dividend Yield
- TCRX N/A
- LFVN 2.21%
- EPS Growth
- TCRX N/A
- LFVN 226.09
- EPS
- TCRX N/A
- LFVN 0.75
- Revenue
- TCRX $6,961,000.00
- LFVN $228,530,000.00
- Revenue This Year
- TCRX $255.18
- LFVN $6.93
- Revenue Next Year
- TCRX N/A
- LFVN $1.43
- P/E Ratio
- TCRX N/A
- LFVN $10.87
- Revenue Growth
- TCRX N/A
- LFVN 14.17
- 52 Week Low
- TCRX $1.02
- LFVN $8.10
- 52 Week High
- TCRX $6.23
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- TCRX 41.52
- LFVN 23.81
- Support Level
- TCRX $2.23
- LFVN $8.50
- Resistance Level
- TCRX $2.43
- LFVN $9.00
- Average True Range (ATR)
- TCRX 0.19
- LFVN 0.40
- MACD
- TCRX -0.04
- LFVN 0.04
- Stochastic Oscillator
- TCRX 1.52
- LFVN 3.57
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.